Disturbance of cerebral neuronal migration following congenital parvovirus B19 infection

Fetal Diagnosis and Therapy

Volumn 24, Issue 4, 2009, Pages 491-494

  Pistorius, Lourens Rasmus ^a,d   Smal, Jaime ^a   De Haan, Timo Robert ^b   Page Christiaens, Godelieve C M L ^a   Verboon Maciolek, Malgorzata ^a   Oepkes, Dick ^c   De Vries, Linda S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Developmental outcome; Fetal magnetic resonance imaging; Fetal transfusion; Parvovirus B19

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BRAIN NERVE CELL; CASE REPORT; CELL MIGRATION; CLINICAL FEATURE; CORDOCENTESIS; ERYTHEMA INFECTIOSUM; FEMALE; FETUS; FETUS ANEMIA; FETUS DISEASE; FETUS HYDROPS; GESTATION PERIOD; HETEROTOPIA; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; MICROGYRIA; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

ADULT; BLOOD TRANSFUSION, INTRAUTERINE; BRAIN; BRAIN DISEASES; CELL MOVEMENT; CHORISTOMA; ENCEPHALITIS, VIRAL; FEMALE; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; ULTRASONOGRAPHY, PRENATAL;

EID: 57049182051     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000180119     Document Type: Article

References (32)

1. Anderson MJ, Higgins PG, Davis LR, et al: Experimental parvoviral infection in humans. J Infect Dis 1985;152:257-265.
2. Enders M, Weidner A, Zoellner I, Searle K, Enders G: Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004;24:513-518.
3. Fairley CK, Smoleniec JS, Caul OE, Miller E: Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995;346:1335-1337.
4. Rodis JF, Borgida AF, Wilson M, et al: Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol 1998;179:985-988.
5. Schild RL, Bald R, Plath H, Eis-Hubinger AM, Enders G, Hansmann M: Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 1999;13:161-166.
6. Rodis JF, Rodner C, Hansen AA, Borgida AF, Deoliveira I, Shulman RS: Long-term outcome of children following maternal human parvovirus B19 infection. Obstet Gynecol 1998;91:125-128.
7. de Jong EP, de Haan TR, Kroes AC, Beersma MF, Oepkes D, Walther FJ: Parvovirus B19 infection in pregnancy. J Clin Virol 2006;36:1-7.
8. Dembinski J, Haverkamp F, Maara H, Hansmann M, Eis-Hubinger AM, Bartmann P: Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. BJOG 2002;109:1232-1234.
9. Nagel HT, de Haan TR, Vandenbussche FP, Oepkes D, Walther FJ: Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 2007;109:42-47.
10. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, et al: Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000;342:9-14.
11. Garel C: MRI of the Fetal Brain. Berlin, Springer, 2004.
12. Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB: A developmental and genetic classification for malformations of cortical development. Neurology 2005;65:1873-1887.
13. Craze JL, Salisbury AJ, Pike MG: Prenatal stroke associated with maternal parvovirus infection. Dev Med Child Neurol 1996;38:84-85.
14. de Haan TR, Wezel-Meijler G, Beersma MF, Von Lindern JS, Van Duinen SG, Walther FJ: Fetal stroke and congenital parvovirus B19 infection complicated by activated protein C resistance. Acta Paediatr 2006;95:863-867.
15. Isumi H, Nunoue T, Nishida A, Takashima S: Fetal brain infection with human parvovirus B19. Pediatr Neurol 1999;21:661-663.
16. Katz VL, McCoy MC, Kuller JA, Hansen WF: An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases. Am J Perinatol 1996;13:43-45.
17. Kerr JR, Barah F, Chiswick ML, et al: Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae. J Neurol Neurosurg Psychiatry 2002;73:739-746.
18. Ergaz Z, Ornoy A: Parvovirus B19 in pregnancy. Reprod Toxicol 2006;21:421-435.
19. O'Malley A, Barry-Kinsella C, Hughes C, et al: Parvovirus infects cardiac myocytes in hydrops fetalis. Pediatr Dev Pathol 2003;6:414-420.
20. Cameron AD, Swain S, Patrick WJ: Human parvovirus B19 infection associated with hydrops fetalis. Aust N Z J Obstet Gynaecol 1997;37:316-319.
21. Miller E, Fairley CK, Cohen BJ, Seng C: Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105:174-178.
22. Hanley JA, Lippman-Hand A: If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 1983;249:1743-1745.
23. Glenn OA, Bianco K, Barkovich AJ, Callen PW, Parer JT: Fetal cerebellar hemorrhage in parvovirus-associated non-immune hydrops fetalis. J Matern Fetal Neonatal Med 2007;20:769-772.
24. Rademaker KJ, Uiterwaal CS, Beek FJ, et al: Neonatal cranial ultrasound versus MRI and neurodevelopmental outcome at school age in children born preterm. Arch Dis Child Fetal Neonatal Ed 2005;90:F489-F493.
25. Whiting S, Duchowny M: Clinical spectrum of cortical dysplasia in childhood: diagnosis and treatment issues. J Child Neurol 1999;14:759-771.
26. Hayward JC, Titelbaum DS, Clancy RR, Zimmerman RA: Lissencephaly- pachygyria associated with congenital cytomegalovirus infection. J Child Neurol 1991;6:109-114.
27. Iannetti P, Nigro G, Spalice A, Faiella A, Boncinelli E: Cytomegalovirus infection and schizencephaly: case reports. Ann Neurol 1998;43:123-127.
28. Marques Dias MJ, Harmant-van Rijckevorsel G, Landrieu P, Lyon G: Prenatal cytomegalovirus disease and cerebral microgyria: evidence for perfusion failure, not disturbance of histogenesis, as the major cause of fetal cytomegalovirus encephalopathy. Neuropediatrics 1984;15:18-24.
29. Soussotte C, Maugey-Laulom B, Carles D, Diard F: Contribution of transvaginal ultrasonography and fetal cerebral MRI in a case of congenital cytomegalovirus infection. Fetal Diagn Ther 2000;15:219-223.
30. Rees S, Stringer M, Just Y, Hooper SB, Harding R: The vulnerability of the fetal sheep brain to hypoxemia at mid-gestation. Brain Res Dev Brain Res 1997;103:103-118.
31. de Vries LS, Gunardi H, Barth PG, Bok LA, Verboon-Maciolek MA, Groenendaal F: The spectrum of cranial ultrasound and magnetic resonance imaging abnormalities in congenital cytomegalovirus infection. Neuropediatrics 2004;35:113-119.
32. Barkovich AJ, Lindan CE: Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. AJNR Am J Neuroradiol 1994;15:703-715.